Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women

Archives of Internal Medicine

Volumn 162, Issue 20, 2002, Pages 2362-2366

  Lee, Euni ^a   Zuckerman, Ilene H ^b,c   Weiss, Sheila R ^b,c  

^a HOWARD UNIVERSITY   (United States)

^b School of Pharmacy   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLECALCIFEROL; ESTROGEN; ETIDRONIC ACID; ORAL CONTRACEPTIVE AGENT; PAMIDRONIC ACID; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; VITAMIN D;

ADULT; AGED; AMBULATORY CARE; ARTICLE; COUNSELING; ESTROGEN THERAPY; FEMALE; HEALTH INSURANCE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICARE; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CALCIUM; CHOLECALCIFEROL; COUNSELING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; OFFICE VISITS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 0037111815     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.20.2362     Document Type: Article

References (23)

1. Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 1998.
2. NIH Consensus Development Panal on Osteoporosis Prevention, Diagnosis, and Treatment. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
3. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-650.
4. Lindsay R, Marcus R, Recker R. Osteoporosis: What's new in prevention and treatment. Patient Care. 1996;30:24-28, 30-31, 35-36.
5. Osteoporosis among estrogen-deficient women - United States, 1988-1994. MMWR Morb Mortal Wkly Rep. 1998;47:969-973.
6. Aufdemorte T. Pathologic assessment of bone. Hosp Pract (Off Ed). 1991;26 (suppl 1):18-22.
7. Meunier PJ, Delmas PD, Eastell R, et al. Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines: International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 1999;21:1025-1044.
8. Lobo RA. Menopause. In: Goldman L, Bennett JC, eds. Cecil Textbook of Medicine. Philadelphia, Pa: WB Saunders Co; 2000:1360-1366.
9. Woodwell DA. National Ambulatory Medical Care Survey. 1997 Summary. Hyattsville, Md: National Center for Health Statistics; 1999. Advance Data From Vital and Health Statistics, No. 305.
10. Woodwell DA. National Ambulatory Medical Care Survey: 1998 Summary. Hyattsville, Md: National Center for Health Statistics; 2000. Advance Data From Vital and Health Statistics, No. 315.
11. National Center for Health Statistics. Public Use Micro-Data File Documentation, National Ambulatory Medical Care Survey, 1997: Data and Documentation Produced by the National Center for Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1997.
12. National Center for Health Statistics. Public Use Micro-Data File Documentation, National Ambulatory Medical Care Survey, 1998: Data and Documentation Produced by the National Center for Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1998.
13. Consensus Development Conference on Osteoporosis: Hong Kong, April 1-2, 1993. Am J Med. 1993;95:1S-78S.
14. National Institute on Aging. Osteoporosis: The Bone Thief. Available at: http://www.nia.nih.gov/health/agepages/osteo.htm. Accessed October 25, 2001.
15. Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768.
16. Stafford RS, Saglam D, Causino N, Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol. 1997;177:381-387.
17. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women, JAMA. 2002;288:321-333.
18. Kirk JK, Spangler JG, Celestino FS. Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older. Pharmacotherapy. 2000;20:405-409.
19. Peacock M, Liu G, Carey M, et al. Effect of calcium or 250H vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011-3019.
20. Nguyen TV, Center JR, Eisman JA. Association between breast cancer and bone mineral density: The Dubbo Osteoporosis Epidemiology Study. Maturitas. 2000;36:27-34.
21. Recker RR. Prevention of osteoporosis: Calcium nutrition. Osteoporos Int. 1993;3:163-165.
22. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd Ed. Baltimore, Md: Williams & Wilkins; 1996.
23. Missed opportunities in preventive counseling for cardiovascular disease-United States, 1995. MMWR Morb Mortal Wkly Rep. 1998;47:91-95.